[Experiences with intense cytostatic therapy of malignant tumors].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002277:Carcinoma / Q000188:drug therapy; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D010954:Plasmacytoma / Q000188:drug therapy; D011087:Polycythemia Vera / Q000188:drug therapy; D012509:Sarcoma / Q000188:drug therapy; D014228:Triaziquone / Q000009:adverse effects / Q000627:therapeutic use*; D014565:Urogenital Neoplasms / Q000188:drug therapy
D003520:Cyclophosphamide; D014228:Triaziquone
Erfahrungen mit der cytostatischen Stosstherapie maligner Tumoren.